AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2021
Aug 6, 2021
35475_dirs_2021-08-06_b96275d2-ee43-4d37-9186-8397e97822e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2021-08-04
Reporting Person: MADDALUNA ANTHONY J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-04 | Stock Option (right to buy) | $8.87 | A | 13750 | Acquired | 2031-08-04 | Common Stock (13750) | Direct |
Footnotes
F1: The stock option vests and becomes exercisable on August 4, 2022.
More from Indaptus Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12
Director's Dealing
2026
Jan 23